Lantern Pharma Inc.
NASDAQ:LTRN
3.91 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 21.938 | 37.202 | 51.524 | 19.229 | 1.232 | 0.445 |
| Short Term Investments
| 19.365 | 17.994 | 19.201 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 41.303 | 55.196 | 70.725 | 19.229 | 1.232 | 0.445 |
| Net Receivables
| 0.86 | 0.592 | 0.181 | 0 | 0 | 0 |
| Inventory
| 0 | -0.592 | -0.181 | 0 | 0 | 0 |
| Other Current Assets
| 1.179 | 3.527 | 1.991 | 1.008 | 0.001 | 0 |
| Total Current Assets
| 43.341 | 58.723 | 72.716 | 20.237 | 1.233 | 0.445 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.28 | 0.096 | 0.216 | 0.022 | 0.009 | 0.005 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.026 | 0.018 | 0.018 | 0.101 | 0.191 | 0 |
| Total Non-Current Assets
| 0.306 | 0.114 | 1.234 | 0.123 | 0.2 | 0.005 |
| Total Assets
| 43.648 | 58.836 | 73.95 | 20.36 | 1.433 | 0.45 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.505 | 2.745 | 2.174 | 0.552 | 0.489 | 0.117 |
| Short Term Debt
| 0.173 | 0.053 | 0.152 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -2,505.211 | -2.745 | -2.174 | 0 | 0 | 0 |
| Other Current Liabilities
| 2,505.211 | 2.745 | 2.174 | 0 | 0 | 0.535 |
| Total Current Liabilities
| 2.678 | 2.798 | 2.326 | 0.552 | 0.489 | 0.652 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.061 | 52.89 | 0.053 | 0.109 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -0 | -52.837 | -0 | -0 | 0 | 0 |
| Total Non-Current Liabilities
| 0.061 | 0.053 | 0.053 | 0.109 | 0 | 0 |
| Total Liabilities
| 2.74 | 2.798 | 2.379 | 0.661 | 0.489 | 0.652 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0.014 | 0.007 |
| Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0.011 | 0.011 |
| Retained Earnings
| -55.244 | -39.283 | -25.023 | -12.66 | -6.752 | -4.324 |
| Accumulated Other Comprehensive Income/Loss
| -0.107 | -0.371 | -0.093 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 96.259 | 95.691 | 96.686 | 32.358 | 7.67 | 4.103 |
| Total Shareholders Equity
| 40.908 | 56.038 | 71.571 | 19.699 | 0.943 | -0.202 |
| Total Equity
| 40.908 | 56.038 | 71.571 | 19.699 | 0.943 | -0.202 |
| Total Liabilities & Shareholders Equity
| 43.648 | 58.836 | 73.95 | 20.36 | 1.433 | 0.45 |